HT-006

N/A

Report date: 2024/01/15 20:08:03
NME

Base Information

Drug NameHT-006
Drug Alias NameHT-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHospital-acquired pneumoniaKeratitisPneumonia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesU.S. Army Medical Research And Development CommandWalter Reed Army Medical CenterHoth Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesU.S. Army Medical Research And Development CommandUniversity Of CincinnatiHoth Therapeutics Inc +[4] 
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaKeratitisPneumonia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A